NCT06096207 - DBS for Depression | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 18, 2023

Primary Completion Date

October 18, 2030

Study Completion Date

October 18, 2038

Conditions

Treatment Resistant Depression

Interventions

DEVICE

Medtronic SenSight Directional DBS lead

At the ninth month post DBS implantation, the participant will enter a discontinuation phase of a duration of 6 weeks. The device will be turned on and off without participants' knowledge. After 6 weeks, the device will be turned back on if it was off. Whether the stimulation is active or not, it will be double blinded.

Trial Locations (1)

11004

RECRUITING

Zucker Hillside Hospital, Queens